Novartis AGNovartis AGNovartis AG

Novartis AG

No trades
See on Supercharts

Price target

128.960.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 28 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NVSEF EPS for the last quarter is 2.25 USD despite the estimation of 2.27 USD. In the next quarter EPS is expected to reach 1.97 USD. Track more of Novartis AG financials and stay on top of what is up with the company.
In the next quarter Novartis AG revenue is expected to reach ‪13.84 B‬ USD. Check out Novartis AG revenue and earnings and make informed decisions.
According to analysts, NVSEF price target is 128.96 USD with a max estimate of 152.88 USD and a min estimate of 104.73 USD. Check if this forecast comes true in a year, meanwhile watch Novartis AG stock price chart and keep track of the current situation with NVSEF news and stock market news.
We've gathered opinions of 28 analysts rating NVSEF stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.